Login / Signup

The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19.

Migliorini FilippoNicola MaffulliTapish ShuklaRiccardo D'AmbrosiMohit SinglaAbhishek VaishRaju Vaishya
Published in: Journal of orthopaedic surgery and research (2024)
It is possible that even time-limited high-dose CCS administration in patients with severe COVID-19 infection increased the incidence of AVN. The mean time elapsed from COVID-19 infection to the development of symptomatic AVN was approximately 80 days. Given the high risk of bias in all the included studies, the quality of recommendations of the present investigation is low, and no reliable conclusion can be inferred.
Keyphrases
  • coronavirus disease
  • sars cov
  • high dose
  • early onset
  • low dose
  • risk factors
  • clinical practice